EUROPE CELLULITE TREATMENT MARKET FORECAST 2023-2032

EUROPE CELLULITE TREATMENT MARKET FORECAST 2023-2032
Europe Cellulite Treatment Market by Procedure (Non-invasive, Minimally Invasive, Topical) Market by Type (Soft Cellulite, Hard Cellulite, Edematous Cellulite) Market by End-user (Hospitals, Clinics and Beauty Centers, Other End-users) by Geography
The Europe cellulite treatment market is estimated to record a CAGR of 9.47% during the projection period of 2023-2032, capturing a revenue share of $1263.03 million by 2032.
Key drivers, such as the increasing adoption of advanced technologies, the launch of new products, and the rising preference towards minimally invasive and non-invasive procedures, are set to augment the region’s market growth. Moreover, the surge in the occurrence of obesity, coupled with the rising aging population, is anticipated to further fuel the demand for cellulite treatment, thus propelling the market growth. However, the Europe cellulite treatment market may be challenged because of the side effects associated with the treatment.
To know more about this report, request a free sample copy
The Europe cellulite treatment market growth evaluation includes an in-depth study of Germany, the United Kingdom, France, Italy, Belgium, Poland, and Rest of Europe. According to the government of the United Kingdom, the data from the Active Lives Adult Survey estimated that nearly 25.3% of adults in England were living with obesity between November 2020 to November 2021. Additionally, according to the Office for National Statistics, more than 11 million people in England and Wales were aged 65 years or older. Hence, the increasing incidence of obesity and the growing aging population is expected to fuel the demand for cellulite treatment in the country over the upcoming years.
On the other hand, according to the estimates issued by the International Society of Aesthetic Plastic Surgery (ISAPS), around 1,082,892 cosmetic procedures were performed in Germany in the year 2021. The ISAPS stated that the country had about 1,550 plastic surgeons, as well. Moreover, the presence of leading market players in Germany, such as Merz Pharma, Inceler Medikal, and others, also ensures the availability of technologically advanced solutions, thus boosting the demand for cellulite treatments and products. As a result, these factors are set to augment the market growth in Europe over the forecasted period.
The Europe cellulite treatment market is segmented into procedure, type, and end-user. The type segment includes soft cellulite, hard cellulite, and edematous cellulite. Also known as flaccid cellulite, soft cellulite refers to the sagginess of the skin around the arms, buttocks, hips, and thighs. The sagginess is mainly caused due to the accumulation of fat in these body parts. Moreover, this type of cellulite is not painful to touch, and feels surging and gelatinous.
Conversely, hard or compact cellulite is a more severe stage of cellulite that can be identified by deep depressions as well as blemishes on the thighs. Hard cellulite may be relatively painful when touched and requires suitable treatment. Dermocosmetics, coupled with lipolytic action, can be effective in terms of combating compact cellulite.
Some of the key players operating in the Europe cellulite treatment market include Inceler Medikal Co Ltd, Zimmer MedizinSysteme, Sinclair Pharma, etc.
Inceler Medikal Co Ltd, headquartered in Germany, is a provider of different products as well as services in the healthcare sector. The company also caters to various segments, including orthopedics, urology, veterinary, and aesthetics. The devices manufactured by the company are designed to integrate advanced technology, high security, economic, as well as aesthetic parameters.
The company’s Modus Cellulite AWT Radial Shockwave Therapy is a device that works in three different modes of treatment. Moreover, the therapy helps fight cellulite, wrinkles, stretch marks, and more.
Report Synopsis
Report Scope |
Details |
Market Forecast Years | 2023-2032 |
Base Year | 2022 |
Market Historical Years | 2018-2022 |
Forecast Units | Revenue ($ Million) |
Segments Analyzed | Procedure, Type, End-User |
Countries Analyzed | Germany, the United Kingdom, France, Italy, Belgium, Poland, and Rest of Europe |
Companies Analyzed |
Johnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, Cutera Inc, Inceler Medikal Co Ltd, Zimmer MedizinSysteme, Galderma SA, Sientra Inc, Endo International PLC, Candela Corporation, Nubway Co Ltd, Sinclair Pharma, Cynosure LLC, Merz Pharma GmbH & Co KGaA, Alma Lasers |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- MAJOR MARKET FINDINGS
- RISING BEAUTY CONSCIOUSNESS
- GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
- RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
- RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
- MARKET DYNAMICS
- KEY DRIVERS
- GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
- RISING CASES OF OBESITY
- RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
- KEY RESTRAINTS
- HIGH COST OF ADVANCED CELLULITE TREATMENT
- SIDE EFFECTS POST-TREATMENT
- LACK OF AWARENESS
- KEY DRIVERS
- KEY ANALYTICS
- PARENT MARKET ANALYSIS
- KEY TECHNOLOGY TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- MARKET MATURITY ANALYSIS
- MARKET CONCENTRATION ANALYSIS
- VALUE CHAIN ANALYSIS
- RESEARCH AND DEVELOPMENT
- PRODUCT DEVELOPMENT
- MARKETING AND DISTRIBUTION
- POST-SALES MONITORING
- KEY BUYING CRITERIA
- COST
- BRAND REPUTATION
- USABILITY
- MARKET BY PROCEDURE
- NON-INVASIVE
- MINIMALLY INVASIVE
- TOPICAL
- MARKET BY TYPE
- SOFT CELLULITE
- HARD CELLULITE
- EDEMATOUS CELLULITE
- MARKET BY END-USER
- HOSPITALS
- CLINICS AND BEAUTY CENTERS
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- EUROPE CELLULITE TREATMENT MARKET DRIVERS
- EUROPE CELLULITE TREATMENT MARKET CHALLENGES
- EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
- COUNTRY ANALYSIS
- UNITED KINGDOM
- UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- GERMANY
- GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- FRANCE
- FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- ITALY
- ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- BELGIUM
- BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- POLAND
- POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- REST OF EUROPE
- REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- UNITED KINGDOM
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- ABBVIE INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- ALMA LASERS
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- BAUSCH HEALTH COMPANIES INC.
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- CANDELA CORPORATION
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- CUTERA INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- CYNOSURE LLC
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- ENDO INTERNATIONAL PLC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- GALDERMA SA
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- INCELER MEDIKAL CO LTD
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- JOHNSON & JOHNSON
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- MERZ PHARMA GMBH & CO KGAA
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- NUBWAY CO LTD
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- SIENTRA INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- SINCLAIR PHARMA
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- ZIMMER MEDIZINSYSTEME
- COMPANY OVERVIEW
- PRODUCTS / SERVICES LIST
- STRENGTHS & CHALLENGES
- ABBVIE INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT
TABLE 2: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: EUROPE CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN EUROPE CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: EUROPE CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: EUROPE CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: EUROPE CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: EUROPE CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: EUROPE CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: EUROPE CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: EUROPE CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: EUROPE CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: EUROPE CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: EUROPE CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: EUROPE CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: EUROPE CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED KINGDOM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: GERMANY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: FRANCE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: ITALY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: BELGIUM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: POLAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: REST OF EUROPE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: ABBVIE INC COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 29: ABBVIE INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 30: ABBVIE INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 31: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 32: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 33: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 34: CUTERA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)
FIGURE 35: CUTERA INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 36: CUTERA INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 37: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 – 2021 ($ MILLION)
FIGURE 38: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 39: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 40: JOHNSON & JOHNSON COMPANY PROFIT 2017 – 2021 ($ BILLION)
FIGURE 41: JOHNSON & JOHNSON COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 42: JOHNSON & JOHNSON COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 43: JOHNSON & JOHNSON COMPANY REVENUE 2017 – 2021 ($ BILLION)
FIGURE 44: SIENTRA INC COMPANY PROFIT 2017 – 2021 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- EUROPE CELLULITE TREATMENT MARKET DRIVERS
- EUROPE CELLULITE TREATMENT MARKET CHALLENGES
- EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
- COUNTRY ANALYSIS
- UNITED KINGDOM
- UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- GERMANY
- GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- FRANCE
- FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- ITALY
- ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- BELGIUM
- BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- POLAND
- POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- REST OF EUROPE
- REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
- UNITED KINGDOM
- EUROPE
- MARKET BY PROCEDURE
- NON-INVASIVE
- MINIMALLY INVASIVE
- TOPICAL
- MARKET BY TYPE
- SOFT CELLULITE
- HARD CELLULITE
- EDEMATOUS CELLULITE
- MARKET BY END-USER
- HOSPITALS
- CLINICS AND BEAUTY CENTERS
- OTHER END-USERS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.